Abbott Laboratories (ABT) Return on Assets ROA from the first quarter of 2026 to first quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abbott Laboratories  (NYSE: ABT)


Abbott Laboratories's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Abbott Laboratories's ROA in the first quarter of 2026?
Abbott Laboratories achieved a return on average assets (ROA) of 6.15 % in its first quarter of 2026, which is below Abbott Laboratories's average return on assets, which stands at 8.06%.

ROA decreased relative to the period ending Dec 31 2025, due to the decline in net income.

However, within the Healthcare sector 130 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 912, from total ROA ranking in the fourth quarter of 2025 at 933.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Total Assets Change 31.86 % 14.85 % 12.78 % 14.77 % 11.53 %
Y / Y Net Income Change -18.72 % -80.76 % -0.12 % 36.64 % 8.16 %
Net Income (TTM) in million 6,276 6,524 13,977 13,979 13,502
Return On Assets (TTM) 6.15 % 6.88 % 15.25 % 15.72 % 15.72 %
ABT's Total Ranking # 912 # 933 # 298 # 286 # 283
Total Assets (TTM) in million 120,775 97,479 95,233 94,816 91,591
Seq. Total Assets Change 23.9 % 2.36 % 0.44 % 3.52 % 7.91 %
Seq. Net Income Change -39.36 % 8.03 % -7.59 % 34.26 % -85.64 %

ABT's 5 Years Annual ROA >> Back to ABT Management Effectiveness >> Compare ABT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 50
Sector # 131
Overall # 906

Return On Assets Statistics
High Average Low
17.79 %
8.06 %
0.93 %
(Dec 31 2024)   (Mar 31 2018)





Financial Statements
Abbott Laboratories's Assets $ 120,775 million ABT's Balance sheet
Abbott Laboratories's Income $ 1,077 million Quarterly ABT's Income Statement
ABT's Income by Division See ABT's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 14.85 % 17.59 % -4.02 % 0.01 % 3.65 %
Total Assets in million 97,479 84,876 72,179 75,204 75,196
Y / Y Net Income Change -51.32 % 134.18 % -17.45 % -1.95 % 57.31 %
Net Income in million 6,524 13,402 5,723 6,933 7,071
Annual Return On Assets 6.69 % 15.79 % 7.93 % 9.22 % 9.4 %

ABT's 5 Years Annual ROA >> Back to ABT Management Effectiveness >> Compare ABT ROA to its Competitors



Comment on ABT's ROA in the fiscal year ending 2025
In the fiscal year 2025 Abbott Laboratories's ROA decreased compared to previous year to 6.69 %, due to deterioration of net income -51.32 % to $6,524.00 million, from $13,402.00 million a year ago, as ABT's assets were $97,479.00 million.


More Return On Assets Ratios
ABT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABT's Competitors
Subscribers only: Roa for Abbott Laboratories's Suppliers
Subscribers only: Return On Assets for ABT's Customers

You may also want to know
ABT's Roi ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons
ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector ROA
Chemed Corporation  16.20 %
Gilead Sciences Inc   16.06 %
Transmedics Group Inc   15.85 %
Inspire Medical Systems inc   15.30 %
Neurocrine Biosciences Inc   15.12 %
Strata Critical Medical Inc   15.09 %
Intuitive Surgical Inc   14.98 %
Halozyme Therapeutics Inc   14.73 %
Profound Medical Corp   13.91 %
Aveanna Healthcare Holdings Inc   13.73 %
Standard Biotools Inc   13.58 %
Illumina Inc   13.40 %
Dexcom Inc   13.39 %
West Pharmaceutical Services Inc   13.21 %
Apellis Pharmaceuticals Inc   13.20 %
Prestige Consumer Healthcare Inc   13.01 %
Hca Healthcare Inc   12.94 %
Lantheus Holdings Inc   12.45 %
Puma Biotechnology Inc   12.09 %
Harmony Biosciences Holdings inc   11.99 %
Carlisle Companies Incorporated  11.97 %
Alnylam Pharmaceuticals Inc   11.71 %
Sbc Medical Group Holdings Incorporated  11.64 %
Medinotec Inc   11.60 %
Encompass Health Corporation  11.56 %
Alpha Pro Tech Ltd   11.43 %
Msa Safety Inc  11.37 %
Globus Medical Inc   11.28 %
Agilent Technologies inc   11.15 %
Ligand Pharmaceuticals Incorporated  11.13 %

Date modified: 2026-07-06T20:12:08+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.